Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
AARD	Aardvark Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$57.59M	n/a	-54.0%	n/a	-$2.93
ABBV	AbbVie Inc. Manufacturing · Year ended 2025-12-31 · USD	$61.16B	$4.23B	6.9%	n/a	8.6%	$2.36
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
ABEO	Abeona Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$71.18M	n/a	44.7%	n/a	$1.01
ABT	Abbott Laboratories Manufacturing · Year ended 2025-12-31 · USD	$44.33B	$6.52B	14.7%	12.5%	5.7%	$3.72
ABUS	Arbutus Biopharma Corp Manufacturing · Year ended 2025-12-31 · USD	$14.08M	-$33.50M	-237.9%	-43.7%	128.2%	-$0.17
ABVC	Abvc Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$296.0K	-$7.91M	n/m	-71.2%	-41.9%	-$0.39
ACAD	Acadia Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$1.07B	$391.00M	36.5%	31.9%	11.9%	$2.30
ACET	Adicet Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$116.80M	n/a	-73.4%	n/a	-$16.95
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
ACRV	Acrivon Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.91M	n/a	-69.2%	n/a	-$2.02
ACTU	Actuate Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.23M	n/a	-280.5%	n/a	-$1.06
ACUT	Accustem Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.76M	n/a	n/a	n/a	-$0.12
ACXP	Acurx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.97M	n/a	-151.2%	n/a	-$5.32
ADAG	Adagene Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.67M	-$17.61M	-229.6%	-49.8%	n/m	-$0.30
ADCT	ADC Therapeutics SA Manufacturing · Year ended 2025-12-31 · USD	$81.36M	-$142.62M	-175.3%	n/a	14.9%	-$1.12
ADIL	Adial Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.98M	n/a	-151.2%	n/a	-$11.93
ADTX	Aditxt, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.2K	-$43.10M	n/m	-768.3%	-97.6%	-$1153.83
AEON	AEON Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.22M	n/a	n/a	n/a	-$3.95
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
AKBA	Akebia Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$236.20M	-$5.34M	-2.3%	-16.4%	47.5%	-$0.02
AKTX	Akari Therapeutics Plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$17.30M	n/a	-61.1%	n/a	$0.00
ALDX	Aldeyra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$33.85M	n/a	-76.5%	n/a	-$0.56
ALKS	Alkermes plc. Manufacturing · Year ended 2025-12-31 · USD	$1.48B	$241.66M	16.4%	13.3%	-5.2%	$1.43
ALLR	Allarity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$320.0K	-$11.23M	n/m	-114.3%	n/a	n/a
ALMS	Alumis Inc. Manufacturing · Year ended 2025-12-31 · USD	$24.05M	-$243.32M	n/m	-80.8%	n/a	-$2.86
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
ALT	Altimmune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.0K	-$88.09M	n/m	-39.2%	105.0%	-$1.00
ALXO	ALX Oncology Holdings Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$101.69M	n/a	-391.4%	n/a	-$1.90
ALZN	Alzamend Neuro, Inc. Manufacturing · Year ended 2026-04-30 · USD	n/a	-$8.77M	n/a	n/m	n/a	-$2.63
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
AMPH	Amphastar Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$719.89M	$98.09M	13.6%	12.4%	-1.7%	$2.03
AMRN	Amarin Corp PLC Manufacturing · Year ended 2025-12-31 · USD	$213.65M	-$38.80M	-18.2%	-8.4%	-6.5%	-$0.09
AMRX	Amneal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02B	$72.06M	2.4%	n/a	8.0%	$0.22
ANAB	Anaptysbio, Inc Manufacturing · Year ended 2025-12-31 · USD	$234.60M	-$13.23M	-5.6%	-35.6%	157.0%	-$0.46
ANEB	Anebulo Pharmaceuticals, Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$8.48M	n/a	-72.8%	n/a	-$0.25
ANIP	ANI Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$883.37M	$78.34M	8.9%	14.5%	43.8%	$3.32
ANIX	Anixa Biosciences Inc Manufacturing · Year ended 2025-10-31 · USD	n/a	-$10.93M	n/a	-72.1%	n/a	-$0.34
ANNX	Annexon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$206.69M	n/a	-97.7%	n/a	-$1.34
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
ANTX	AN2 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.17M	n/a	-66.3%	n/a	-$1.16
ANVS	Annovis Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$28.85M	n/a	-171.2%	n/a	-$1.40
APRE	Aprea Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.60M	n/a	-101.3%	n/a	-$1.93
APUS	Apimeds Pharmaceuticals US, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$6.00M	n/a	-3.9%	n/a	-$0.55
APVO	Aptevo Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.97M	n/a	-149.4%	n/a	-$87.27
AQST	Aquestive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.55M	-$83.78M	-188.1%	n/a	-22.6%	-$0.78
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
ARQT	Arcutis Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$372.07M	-$16.14M	-4.3%	-8.5%	123.4%	-$0.13
ARTL	Artelo Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.88M	n/a	n/a	n/a	-$12.52
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
ARWR	Arrowhead Pharmaceuticals, Inc. Manufacturing · Year ended 2025-09-30 · USD	$829.45M	$30.11M	3.6%	6.0%	n/m	-$0.01
ASBP	Aspire Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.2K	-$24.48M	n/m	n/a	n/a	-$16.38
ASMB	Assembly Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$72.30M	-$6.12M	-8.5%	-3.0%	153.5%	-$0.55
ATNM	Actinium Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$90.0K	-$33.89M	n/m	-432.6%	n/a	-$1.09
ATOS	Atossa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.77M	n/a	-88.4%	n/a	-$4.04
ATXI	Avenue Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40M	-$2.91M	-207.2%	-158.8%	n/a	n/a
AUPH	Aurinia Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$287.20M	n/a	49.4%	n/a	$2.07
AVBP	ArriVent BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$166.31M	n/a	-54.1%	n/a	-$4.32
AVIR	Atea Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$158.35M	n/a	-57.5%	n/a	-$1.94
AVTX	Avalo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$59.0K	-$78.26M	n/m	-94.2%	-86.6%	-$5.84
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
AYTU	Aytu Biopharma, Inc Manufacturing · Year ended 2026-06-30 · USD	$57.57M	-$14.25M	-24.8%	-40.4%	-13.3%	n/a
AZTR	Azitra, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.96M	n/a	-288.2%	-100.0%	-$2.25
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
BBOT	BridgeBio Oncology Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$134.04M	n/a	-32.6%	n/a	-$4.30
BCAX	Bicara Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$137.95M	n/a	-34.4%	n/a	-$2.52
BCTX	BriaCell Therapeutics Corp. Manufacturing · Year ended 2025-07-31 · USD	n/a	-$26.31M	n/a	-151.8%	n/a	-$62.19
BCYC	Bicycle Therapeutics PLC Manufacturing · Year ended 2025-12-31 · USD	$72.59M	-$218.96M	-301.7%	-35.9%	105.8%	-$3.16
BDPT	Bioadaptives, Inc. Manufacturing · Year ended 2025-12-31 · USD	$18.3K	-$1.56M	n/m	n/a	44.3%	-$0.15
BFRG	BullFrog AI Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$116.7K	-$6.50M	n/m	-304.2%	n/a	-$0.63
BFRI	Biofrontera Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.70M	-$10.54M	-25.3%	-100.5%	11.7%	-$1.04
BGM	BGM Group Ltd. Manufacturing · Year ended 2025-09-30 · USD	$37.92M	-$19.94M	-52.6%	-5.1%	51.1%	-$0.18
BHC	Bausch Health Companies Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.27B	$120.00M	1.2%	31.8%	6.7%	$0.42
BHST	Bioharvest Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	$34.51M	-$11.13M	-32.3%	-43.8%	37.0%	n/a
BHVN	Biohaven Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$738.82M	n/a	n/m	n/a	-$6.86
BIOA	BioAge Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$8.99M	-$80.61M	-896.1%	-29.6%	n/a	-$2.24
BIOE	Bio Essence Corp Manufacturing · Year ended 2025-12-31 · USD	$1.90M	$896.2K	47.2%	n/a	485.8%	n/a
BIVI	Biovie Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$22.07M	n/a	-214.9%	n/a	-$3.05
BIXT	Bioxytran, Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$2.12M	n/a	n/a	n/a	-$0.02
BLTE	Belite Bio, Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.61M	n/a	-10.1%	n/a	-$2.31
BMEA	Biomea Fusion, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$61.80M	n/a	-209.1%	n/a	-$1.18
BMRN	BioMarin Pharmaceutical Inc Manufacturing · Year ended 2025-12-31 · USD	$3.22B	$348.90M	10.8%	5.7%	12.9%	$1.80
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
BNTC	Benitec Biopharma Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$45.55M	n/a	-25.7%	n/a	-$0.98
BOLD	Boundless Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$58.20M	n/a	-59.0%	n/a	-$2.60
BOLT	Bolt Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.70M	-$33.38M	-433.7%	-125.9%	0.1%	-$17.85
BTAIQ	BioXcel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$642.0K	-$69.90M	n/m	n/a	-71.7%	-$5.73
BYSI	BeyondSpring Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.01M	n/a	n/a	n/a	n/a
CALC	CalciMedica, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.56M	n/a	n/a	n/a	-$1.97
CAMP	Camp4 Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.50M	-$80.40M	n/m	-168.5%	436.5%	-$2.65
CANF	Can-Fite BioPharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$405.0K	-$9.83M	n/m	-175.8%	-39.9%	-$5.97
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
CASIF	CASI Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.71M	-$48.06M	-232.0%	n/a	-27.4%	-$2.59
CATX	Perspective Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.12M	n/a	-49.8%	n/a	-$1.40
CBIO	Crescent Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.84M	-$153.94M	n/m	-75.8%	n/a	n/a
CDT	CDT Equity Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.22M	n/a	n/a	n/a	-$1177.89
CELU	Celularity Inc Manufacturing · Year ended 2025-12-31 · USD	$26.55M	-$91.72M	-345.4%	n/a	-51.0%	-$3.59
CING	Cingulate Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.45M	n/a	-894.8%	n/a	-$4.44
CLNN	Clene Inc. Manufacturing · Year ended 2025-12-31 · USD	$200.0K	-$26.17M	n/m	n/a	-41.5%	n/a

Rows per page: 25 50100